Havana Cuba Business Travel Culture and Politics

Havana Cuba News

Cuba Culture News

Posted December 28, 2005 by publisher in Cuban Healthcare

Email this article | Print this article | Search Havana Journal        

Prensa Latina

Cuba officially registered three new therapeutic vaccines -Valergen-dp, Valergen-ds and Valergen- in 2005 engineered to treat patients with respiratory allergies.

These immunizing agents will be distributed through the national health system in 2006, and constitute one of the achievements Cuban scientists accomplished in the current year.

The HR3 monoclonal antibody was registered in China, Colombia and Argentina, together with the start of exports to the latter two countries.

The chemical, structural and pharmacological characterization of a new biological reagent for biomedical research is also among achievements in 2005, among others.

Exports of Cuban medicines accounted for one hundred million dollars, and of 258 projects started in 2005, 48 were completed.

In the fields of science and technology, meteorological services, Physics, Mathematics and Computing were also developed.

Would you like to add more information?

Only members can add more information. Please register or log in

  • Advertise at Havana Journal Inc
We recommend this AirBnB Food and Drink Experience... Cuban flavors: Food, Rum and Cigars
Images of Cuba
Museo de la Revolucion
Follow Havana Journal
SUBSCRIBE to our Cuba Watch newsletter
LIKE us on Facebook

FOLLOW us on Twitter

CONNECT with us on Linked In

Section Archive
Havana Journal, Inc. BBB Business Review

Member of the Association for the Study of the Cuban Economy